NASDAQ
Inhibitor Therapeutics, Inc. (INTI) has a revenue compound annual growth rate of -39.93% over 5 years and -17.86% over 10 years. Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.
No price data available for this timeframe.